McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for MCK
+1.38 (0.93%)
After Hours: 149.88 0.00 (0.00%)
Mar 28, 5:45PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 147.76 - 150.10
52 week 114.53 - 199.43
Open 148.00
Vol / Avg. 1.79M/1.69M
Mkt cap 31.78B
P/E 16.54
Div/yield 0.28/0.75
EPS 9.06
Shares 212.00M
Beta 1.09
Inst. own 89%
Jan 25, 2017
Q3 2017 McKesson Corp Earnings Release (Estimated)
Jan 10, 2017
McKesson Corp at JPMorgan Healthcare Conference(Q&A)
Jan 10, 2017
McKesson Corp at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 1.29% 1.23%
Operating margin 1.65% 1.86%
EBITD margin - 2.43%
Return on average assets 4.48% 4.24%
Return on average equity 29.76% 27.06%
Employees 68,000 -
CDP Score - -


1 Post St
SAN FRANCISCO, CA 94104-5203
United States - Map
+1-415-9838300 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Kathleen D. McElligott Executive Vice President, Chief Technology Officer, Chief Information Officer
Age: 60
Bio & Compensation  - Reuters
Lori Ann Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Age: 54
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 55
Bio & Compensation  - Reuters
Patrick J Blake Executive Vice President, Group President
Age: 52
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 60
Bio & Compensation  - Reuters
Bansi Nagji Executive Vice President - Corporate Strategy and Business Development
Age: 51
Bio & Compensation  - Reuters
Edward A. Mueller Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 66
Bio & Compensation  - Reuters